Within-trial resource utilization and costs of patients randomized to treatment with imatinib (STI571) versus interferon-alpha (IFN-alpha) combined with cytarabine (Ara-C) in newly diagnosed patients with chronic myeloid leukemia in chronic phase.

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Reed, SD; Radeva, JI; Glendenning, A; Schulman, KA

Published Date

  • November 16, 2002

Published In

Volume / Issue

  • 100 / 11

Start / End Page

  • 187A - 187A

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 44th Annual Meeting of the American-Society-of-Hematology

Conference Location

  • PHILADELPHIA, PENNSYLVANIA

Conference Start Date

  • December 6, 2002

Conference End Date

  • December 10, 2002